CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Open-market sale Director sold 20,070 shares at $5.09 ($102,168)
- 4 Open-market sale Director sold 14,814 shares at $5.09 ($75,412)
- 4 Open-market sale Director sold 16,284 shares at $5.09 ($82,895)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 18,065 shares at $5.09 ($91,962)
- 4 Open-market sale Director sold 2,000 shares at $5.09 ($10,181)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Grant or award Director acquired 37,313 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 12,610 shares at $5.29 ($66,658)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 18,666 shares at $5.33 ($99,507)
Page 5 of 66 · 1,318 filings